Will pCR and Pembro Redefine Breast Cancer Treatment?
Archived series ("HTTP Redirect" status)
Replaced by: Medscape Oncology
When?
This feed was archived on January 22, 2018 19:33 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 181366298 series 9914
By Medscape Oncology. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Dr Laura Esserman discusses the ground-breaking I-SPY breast cancer research platform and its most 'exciting' results to date, indicating that pembrolizumab triples pCR in TNBC.
…
continue reading
149 episodes
Share
))
